Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-01-10 16:14:17
Reporting Period:
Filing Date:
Accepted Time:
2014-01-10 16:14:17
Original Submission Date:
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1429260 Coronado Biosciences Inc CNDO Pharmaceutical Preparations (2834) 205157386
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542419 Lucy Lu C/o Coronado Biosciences, Inc.
24 New England Executive Park
Burlington MA 01803
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2013-07-17 4,545 $7.90 19,524 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $8.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.